Ea
ERDERA Accelerator
Bridging the gap between scientific discovery and investment-ready innovation for rare disease breakthroughs.
ERDERA Accelerator
The ERDERA Public-Private Collaboration Accelerator (PPCA) empowers researchers to turn promising translational ideas into investor-ready projects able to improve the lives of people living with rare diseases. By combining tailored scientific guidance with access to a unique European ecosystem of public and private partners, we help you de-risk and advance your work at the discovery and pre-clinical stages.
You are a researcher…
…working on a rare-disease translational project—within academia, a hospital, or an early start-up.
…with a therapeutic solution, target, or advanced concept that needs strategic support to reach the next milestone.
…looking for guidance, resources, and partners to give your project the best chance of reaching patients.
If this sounds like you, the PPCA can help.
The PPCA supports researchers by:
- Providing complimentary, hands-on advice from experts in drug discovery, pre-clinical development, regulatory science, and market access.
- Facilitating collaboration with relevant public and private stakeholders, including industry partners, patient organisations, and investors.
- Co-creating tailored development plans that strengthen your data package and clarify next milestones.
- Opening doors to in-kind contributions, specialised platforms, and follow-on funding opportunities across Europe.
- Offering all support without claiming intellectual-property ownership.
How we work
We accelerate high-potential projects by de-risking them in discovery and pre-clinical stages through:
- Individualised development roadmaps and expert input.
- Early, structured engagement with industry, investors, and patient communities.
- Public-private collaborations, partnerships, and investor connections.
- Close alignment with ERDERA infrastructures and external resources to bridge gaps with key stakeholders.
Who can apply
- Academic teams, clinicians, and early start-ups based in Europe.
- Projects focused exclusively on rare diseases.
- Early-stage concepts (discovery to pre-clinical proof-of-concept) with strong translational potential.
Our services are free for beneficiaries.
Ready to connect?
Reach out to the ERDERA Public-Private Collaboration Accelerator.
A member of the team will review your submission and be in touch to discuss the next steps.
ERDERA ACCELERATOR
Exploring consultancy needs for rare disease research
“The notion that public-private collaboration is inherently problematic doesn’t align with current realities. Not only is it possible—it is necessary, beneficial, and more straightforward than many assume.”
